Display options
Share it on

Open J Cardiovasc Surg. 2017 Jun 22;9:1179065217714216. doi: 10.1177/1179065217714216. eCollection 2017.

Driveline Infection in Ventricular Assist Devices and Its Implication in the Present Era of Destination Therapy.

Open journal of cardiovascular surgery

Gabriel A Hernandez, Jonatan D Nunez Breton, Sandra V Chaparro

Affiliations

  1. Cardiovascular Division, University of Miami Hospital and Jackson Memorial Hospital, University of Miami Leonard M. Miller School of Medicine, Miami, FL, USA.
  2. Department of Internal Medicine, University of Miami Hospital and Jackson Memorial Hospital, University of Miami Leonard M. Miller School of Medicine, Miami, FL, USA.

PMID: 28680268 PMCID: PMC5489074 DOI: 10.1177/1179065217714216

Abstract

Advances in mechanical circulatory support devices provided the technology to develop long-term, implantable left ventricular assist devices as bridge to transplant, destination therapy, and in a lesser group of patients, as bridge to recovery. Despite the benefits from this innovative therapy, with their increased use, many complications have been encountered, one of the most common being infections. With the driveline acting as a portal to the exterior environment, an infection involving this structure is the most frequent one. Because patients with destination therapy are expected to receive circulatory support for a longer period of time, we will focus this review on the risk factors, prevention, and treatment options for driveline infections.

Keywords: Heart failure; device-related infections; driveline infections; heart-assist devices

Conflict of interest statement

DECLARATION OF CONFLICTING INTERESTS: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

  1. J Am Coll Cardiol. 2011 May 10;57(19):1890-8 - PubMed
  2. ASAIO J. 2016 May-Jun;62(3):291-6 - PubMed
  3. Am Heart J. 2007 Aug;154(2):260-6 - PubMed
  4. J Heart Lung Transplant. 2013 Feb;32(2):157-87 - PubMed
  5. Can J Cardiol. 2014 Mar;30(3):296-303 - PubMed
  6. N Engl J Med. 2009 Dec 3;361(23):2241-51 - PubMed
  7. J Thorac Dis. 2015 Dec;7(12):2151-7 - PubMed
  8. Circ Heart Fail. 2012 Mar 1;5(2):241-8 - PubMed
  9. N Engl J Med. 2009 Dec 3;361(23):2282-5 - PubMed
  10. Circulation. 2012 Nov 27;126(22):2648-67 - PubMed
  11. Infez Med. 2015 Sep;23 (3):261-4 - PubMed
  12. Ann Thorac Surg. 2016 Jan;101(1):87-94; discussion 94 - PubMed
  13. Clin Infect Dis. 2013 Nov;57(10):1438-48 - PubMed
  14. Clin Infect Dis. 2002 May 15;34(10):1295-300 - PubMed
  15. ASAIO J. 2005 Jul-Aug;51(4):461-70 - PubMed
  16. Artif Organs. 2014 Oct;38(10):875-9 - PubMed
  17. J Card Fail. 2015 Feb;21(2):119-25 - PubMed
  18. Transpl Infect Dis. 2014 Jun;16(3):453-60 - PubMed
  19. Lancet Infect Dis. 2006 Jul;6(7):426-37 - PubMed
  20. J Heart Lung Transplant. 2011 Apr;30(4):375-84 - PubMed
  21. Ann Thorac Surg. 2007 Aug;84(2):515-20 - PubMed
  22. Interact Cardiovasc Thorac Surg. 2014 Apr;18(4):415-7 - PubMed
  23. Circulation. 2001 Jan 16;103(2):231-7 - PubMed
  24. Emerg Infect Dis. 2016 Mar;22(3):389-95 - PubMed
  25. Gen Thorac Cardiovasc Surg. 2015 Jan;63(1):1-7 - PubMed
  26. Clin Infect Dis. 2005 Apr 15;40(8):1108-15 - PubMed
  27. Ann Thorac Surg. 2004 Dec;78(6):2123-9; discussion 2129-30 - PubMed
  28. Circulation. 2015 Jan 27;131(4):e29-322 - PubMed
  29. J Heart Lung Transplant. 2015 Dec;34(12 ):1495-504 - PubMed
  30. J Heart Lung Transplant. 2015 Jun;34(6):781-9 - PubMed
  31. Ann Thorac Surg. 2015 Nov;100(5):1920-2 - PubMed
  32. Tex Heart Inst J. 2015 Dec 01;42(6):522-7 - PubMed
  33. J Thorac Cardiovasc Surg. 2011 May;141(5):1259-64 - PubMed
  34. Circulation. 2013 Feb 12;127(6):691-702 - PubMed
  35. Ann Thorac Surg. 2001 Sep;72(3):725-30 - PubMed
  36. Cardiol Clin. 2011 Nov;29(4):515-27 - PubMed

Publication Types